Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01232556
Brief Title: A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy

First Submitted : October 27, 2010
First Submitted that Met QC Criteria : October 29, 2010
First Posted : November 2, 2010 (Estimate)

Results First Submitted : July 17, 2017
Results First Submitted that Met QC Criteria : July 24, 2018
Results First Posted : August 21, 2018

Certification/Extension First Submitted : May 29, 2014
Certification/Extension First Submitted that Met QC Criteria : May 29, 2014
Certification/Extension First Posted : June 2, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : December 19, 2018
Last Update Posted : January 8, 2019